Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial

by Felip, Enriqueta, Altorki, Nasser, Zhou, Caicun, Csőszi, Tibor, Vynnychenko, Ihor, Goloborodko, Oleksandr, Luft, Alexander, Akopov, Andrey, Martinez-Marti, Alex, Kenmotsu, Hirotsugu, Chen, Yuh-Min, Chella, Antonio, Sugawara, Shunichi, Voong, David, Wu, Fan, Yi, Jing, Deng, Yu, McCleland, Mark, Bennett, Elizabeth, Gitlitz, Barbara, Wakelee, Heather
Published in The Lancet (British edition)

Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label p...

by Brahmer, Julie R, Rodríguez-Abreu, Delvys, Robinson, Andrew G, Hui, Rina, Csőszi, Tibor, Fülöp, Andrea, Gottfried, Maya, Peled, Nir, Tafreshi, Ali, Cuffe, Sinead, O'Brien, Mary, Rao, Suman, Hotta, Katsuyuki, Zhang, Jin, Lubiniecki, Gregory M, Deitz, Anne C, Rangwala, Reshma, Reck, Martin
Published in The lancet oncology

Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a rando...

by Di Leo, Angelo, Johnston, Stephen, Lee, Keun Seok, Ciruelos, Eva, Lønning, Per E, Janni, Wolfgang, O'Regan, Ruth, Mouret-Reynier, Marie-Ange, Kalev, Dimitar, Egle, Daniel, Csőszi, Tibor, Bordonaro, Roberto, Decker, Thomas, Tjan-Heijnen, Vivianne C G, Blau, Sibel, Schirone, Alessio, Weber, Denis, El-Hashimy, Mona, Dharan, Bharani, Sellami, Dalila, Bachelot, Thomas
Published in The lancet oncology

Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study

by Dasari, Arvind, Lonardi, Sara, Garcia-Carbonero, Rocio, Elez, Elena, Yoshino, Takayuki, Sobrero, Alberto, Yao, James, García-Alfonso, Pilar, Kocsis, Judit, Cubillo Gracian, Antonio, Sartore-Bianchi, Andrea, Satoh, Taroh, Randrian, Violaine, Tomasek, Jiri, Chong, Geoff, Paulson, Andrew Scott, Masuishi, Toshiki, Jones, Jeremy, Csőszi, Tibor, Cremolini, Chiara, Ghiringhelli, Francois, Shergill, Ardaman, Hochster, Howard S, Krauss, John, Bassam, Ali, Ducreux, Michel, Elme, Anneli, Faugeras, Laurence, Kasper, Stefan, Van Cutsem, Eric, Arnold, Dirk, Nanda, Shivani, Yang, Zhao, Schelman, William R, Kania, Marek, Tabernero, Josep, Eng, Cathy
Published in The Lancet (British edition)

Trilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy‐induced myelosuppression in patients with small cell lung cancer: Pooled analy...

by Ferrarotto, Renata, Anderson, Ian, Medgyasszay, Balazs, García‐Campelo, Maria Rosario, Edenfield, William, Feinstein, Trevor M., Johnson, Jennifer M., Kalmadi, Sujith, Lammers, Philip E., Sanchez‐Hernandez, Alfredo, Pritchett, Yili, Morris, Shannon R., Malik, Rajesh K., Csőszi, Tibor
Published in Cancer medicine (Malden, MA)

Blood tumor mutational burden and response to pembrolizumab plus chemotherapy in non–small cell lung cancer: KEYNOTE-782

by Bar, Jair, Esteban, Emilio, Rodríguez-Abreu, Delvys, Aix, Santiago Ponce, Szalai, Zsuzsanna, Felip, Enriqueta, Gottfried, Maya, Provencio, Mariano, Robinson, Andrew, Fülöp, Andrea, Rao, Suman Bannur, Camidge, D. Ross, Speranza, Giovanna, Townson, Steven M., Kobie, Julie, Ayers, Mark, Dettman, E.J., Hunkapiller, Nathan, McDaniel, Robert, Jung, Byoungsok, Burkhardt, David, Mauntz, Ruth, Csőszi, Tibor
Published in Lung cancer (Amsterdam, Netherlands)

Pathologic Complete Response Rates After Neoadjuvant Pertuzumab and Trastuzumab with Chemotherapy in Early Stage HER2-Positive Breast Cancer - Increasing Rates of Breast Conserving...

by Boér, Katalin, Kahán, Zsuzsanna, Landherr, László, Csőszi, Tibor, Máhr, Károly, Ruzsa, Ágnes, Horváth, Zsolt, Budai, Barna, Rubovszky, Gábor
Published in Pathology oncology research

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

by Powles, Thomas, Oudard, Stephane, Vulsteke, Christof, Fléchon, Aude, Yu, Evan Y, Imai, Kentaro, Homet Moreno, Blanca, Alva, Ajjai, Lazzaro, Mauricio Fernandez, Gatica, Gabriela, Van Aelst, Filip, Machiels, Jean-Pascal, Schallier, Denis, Brust, Leandro, Soares, Joao Paulo Holanda, Cheng, Susanna, Leal, Jose Luis, Ibanez, Carolina, Laguerre, Brigitte, Flechon, Aude, Topart, Delphine, Huillard, Olivier, Gravis, Gwenaelle, Reichardt, Peter, Herden, Jan, Pfister, David, Niegisch, Guenter, Boegemann, Martin, Gakis, Georgios, Neisius, Andreas, Thomas, Christian, Kosa, Judit Erzsebet, Bodoky, Gyorgy, Geczi, Lajos, Frank, Stephen Jay, Kejzman, Daniel, Rosenbaum, Eli, Rouvinov, Keren, Arai, Gaku, Takayama, Tatsuya, Fujimoto, Kiyohide, Tanikawa, Toshiki, Tomita, Yoshihiko, Nishimura, Kazuo, Tsujihata, Masao, Takano, Toshimi, Joraku, Akira, Kobayashi, Kazuki, De Wit, Ronald, Aarts, Maureen, Beerepoot, Laurens, Alekseev, Sergey M, Zyryanov, Alexander, Oschepkov, Vasiliy Nikolaevich, Shidin, Vladimir Aleksandrovich, Karlov, Petr Alexandrovich, Cohen, Graham Lawrence, Ruff, Paul, Lee, Nari, Rodriguez-Vida, Alejo, Grande, Enrique, Munoz Langa, Jose, Montesa Pino, Alvaro, Su, Wen-Pin, Chang, Yen-Hwa, Huang, Yi-Hsiu, Srimuninnimit, Vichien, Abali, Huseyin, Sendur, Mehmet Ali Nahit, Ozguroglu, Mustafa, Ozdogan, Mustafa, Evans, Linda, Hussain, Syed, DiSimone, Christopher, Schlegel, Peter, Mamtani, Ronac, Wallace, James, Suh, Jason Jung-Gon, Burgess, Earle, Wong, John, Chaudhry, Arvind, Thomas, Christian A, Fitzharris, John T, Oliff, Ira A, Vuky, Jacqueline, Hauke, Ralph, Joshi, Monika, Bolemon, Britt H, Markus, Maurice, Pfanzelter, Nicklas, Lawler, William Eyre, Courtright, Jay G, Doshi, Gurjyot, Sartor, Oliver Alton, Mannuel, Heather D, Alva, Ajjai, Charles, Anthony, Ades, Steven, Yu, Evan, Fleming, Mark
Published in The lancet oncology

Patient-Reported Health-Related Quality of Life in KEYNOTE-604: Pembrolizumab or Placebo Added to Etoposide and Platinum as First-Line Therapy for Extensive-Stage SCLC

by Kim, Hye Ryun, Awad, Mark M., Navarro, Alejandro, Gottfried, Maya, Peters, Solange, Csőszi, Tibor, Cheema, Parneet K., Rodriguez-Abreu, Delvys, Wollner, Mirjana, Yang, James Chih-Hsin, Mazieres, Julien, Orlandi, Francisco J., Luft, Alexander, Gümüş, Mahmut, Kato, Terufumi, Kalemkerian, Gregory P., Luo, Yiwen, Santorelli, Melissa L., Pietanza, M. Catherine, Rudin, Charles M.
Published in JTO clinical and research reports

Results of a prospective dose intensity and neutropenia prophylaxis evaluation programme (DIEPP) in cancer patients at risk of febrile neutropenia due to myelosuppressive chemother...

by Mądry, Radosław, Popławska, Lidia, Haslbauer, Ferdinand, Šafanda, Martin, Ghizdavescu, Doru, Benkovicova, Jana, Csőszi, Tibor, Mihaylov, Georgi, Niepel, Daniela, Jaeger, Christine, Frkanova, Iveta, Macovei, Alina, Staudigl, Christine
Published in Wiener Klinische Wochenschrift

Efficacy and safety of oral palonosetron compared with IV palonosetron administered with dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in pati...

by Karthaus, Meinolf, Tibor, Csőszi, Lorusso, Vito, Singh-Arora, Rajender, Filippov, Alexander, Rizzi, Giada, Borroni, Maria Elisa, Rossi, Giorgia, Grunberg, Steven M.
Published in Supportive care in cancer

Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in th...

by Martín, Miguel, Zielinski, Christoph, Ruiz-Borrego, Manuel, Carrasco, Eva, Ciruelos, Eva M., Muñoz, Montserrat, Bermejo, Begoña, Margelí, Mireia, Csöszi, Tibor, Antón, Antonio, Turner, Nicholas, Casas, María I., Morales, Serafín, Alba, Emilio, Calvo, Lourdes, de la Haba-Rodríguez, Juan, Ramos, Manuel, Murillo, Laura, Santaballa, Ana, Alonso-Romero, José L., Sánchez-Rovira, Pedro, Corsaro, Massimo, Huang, Xin, Thallinger, Christiane, Kahan, Zsuzsanna, Gil-Gil, Miguel
Published in European journal of cancer (1990)

Safety and Efficacy of Everolimus With Exemestane vs. Exemestane Alone in Elderly Patients With HER2-Negative, Hormone Receptor–Positive Breast Cancer in BOLERO-2

by Pritchard, Kathleen I, Burris, Howard A, Ito, Yoshinori, Rugo, Hope S, Dakhil, Shaker, Hortobagyi, Gabriel N, Campone, Mario, Csöszi, Tibor, Baselga, José, Puttawibul, Puttisak, Piccart, Martine, Heng, Daniel, Noguchi, Shinzaburo, Srimuninnimit, Vichien, Bourgeois, Hugues, Gonzalez Martin, Antonio, Osborne, Karen, Panneerselvam, Ashok, Taran, Tetiana, Sahmoud, Tarek, Gnant, Michael
Published in Clinical breast cancer

OA05.05 Randomized Phase 2 Study: Alisertib (MLN8237) or Placebo + Paclitaxel as Second-Line Therapy for Small-Cell Lung Cancer (SCLC)

by Owonikoko, Taofeek, Nackaerts, Kristiaan, Csoszi, Tibor, Ostoros, Gyula, Baik, Christina, Ullmann, Claudio Dansky, Zagadailov, Erin, Sheldon-Waniga, Emily, Huebner, Dirk, Leonard, E Jane, Spigel, David
Published in Journal of thoracic oncology

P3.02b-045 Patritumab plus Erlotinib in EGFR Wild-Type Advanced Non–Small Cell Lung Cancer (NSCLC): Part a Results of HER3-Lung Study: Topic: EGFR Clinical

by Paz-Arez, Luis, Serwatowski, Piotr, Szczęsna, Aleksandra, Von Pawel, Joachim, Toschi, Luca, Tibor, Csőszi, Morabito, Alessandro, Zhang, Ling, Shuster, Dale, Chen, Shuquan, Copigneaux, Catherine, Akerley, Wallace
Published in Journal of thoracic oncology

P3.02b-045 Patritumab plus Erlotinib in EGFR Wild-Type Advanced Non–Small Cell Lung Cancer (NSCLC): Part a Results of HER3-Lung Study

by Paz-Arez, Luis, Serwatowski, Piotr, Szczęsna, Aleksandra, Von Pawel, Joachim, Toschi, Luca, Tibor, Csőszi, Morabito, Alessandro, Zhang, Ling, Shuster, Dale, Chen, Shuquan, Copigneaux, Catherine, Akerley, Wallace
Published in Journal of thoracic oncology

Abstract CT216: Response to first-line (1L) pembrolizumab (pembro) + chemotherapy (chemo) in non-small cell lung cancer (NSCLC) by blood tumor mutational burden (bTMB): the phase 2...

by Bar, Jair, Esteban, Emilio, Rodríguez-Abreu, Delvys, Aix, Santiago Ponce, Szalai, Zsuzsanna, Felip, Enriqueta, Gottfried, Maya, Pulla, Mariano Provencio, Robinson, Andrew, Fülöp, Andrea, Rao, Suman B., Camidge, D. Ross, Speranza, Giovanna, Townson, Steven M., Kobie, Julie, Ayers, Mark, Dettman, Elisha J., McDaniel, Robert, Jung, Byoungsok, Burkhardt, David, Mauntz, Ruth, Csőszi, Tibor
Published in Cancer research (Chicago, Ill.)

P3.02c-030 Use of a 200-Mg Fixed Dose of Pembrolizumab for the Treatment of Advanced Non–Small Cell Lung Cancer (NSCLC): Topic: IT

by Garon, Edward, Reck, Martin, Rodríguez-Abreu, Delvys, Robinson, Andrew, Hui, Rina, Tibor, Csőszi, Fülöp, Andrea, Gottfried, Maya, Peled, Nir, Tafreshi, Ali, Cuffe, Sinead, O'Brien, Mary, Rao, Suman, Hotta, Katsuyuki, Turner, David, Stone, Julie, Rangwala, Reshma, Brahmer, Julie
Published in Journal of thoracic oncology

P3.02c-030 Use of a 200-Mg Fixed Dose of Pembrolizumab for the Treatment of Advanced Non–Small Cell Lung Cancer (NSCLC)

by Garon, Edward, Reck, Martin, Rodríguez-Abreu, Delvys, Robinson, Andrew, Hui, Rina, Tibor, Csőszi, Fülöp, Andrea, Gottfried, Maya, Peled, Nir, Tafreshi, Ali, Cuffe, Sinead, O'Brien, Mary, Rao, Suman, Hotta, Katsuyuki, Turner, David, Stone, Julie, Rangwala, Reshma, Brahmer, Julie
Published in Journal of thoracic oncology

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, op...

by Burtness, Barbara, Greil, Richard, de Castro, Gilberto, Fuereder, Thorsten, Ngamphaiboon, Nuttapong, Wan Ishak, Wan Zamaniah, Hong, Ruey-Long, González Mendoza, René, Zhang, Yayan, Gumuscu, Burak, Boyer, Michael, Hughes, Brett, Rischin, Danny, Taylor, Anne, Burian, Martin, Barrios, Carlos Henrique, de Castro Junior, Dalvaro Oliveira, Franke, Fabio Andre, Girotto, Gustavo, Lima, Iane Pinto Figueiredo, Nicolau, Ulisses Ribaldo, Santos, Lucas, Victorino, Ana-Paula, Chua, Neil, Couture, Felix, Hansen, Aaron, Hilton, John, McCarthy, Joy, Soulieres, Denis, Ascui, Rodrigo, Villanueva, Luis, Kral, Zdenek, Prausova, Jana, Vosmik, Milan, Jurgens, Hannes, Putnik, Kadri, Gruenwald, Viktor, Boukovinas, Ioannis, Psyrri, Amanda, Kwong, Dora, Csoszi, Tibor, Horvai, Geza, Landherr, Laszlo, Szota, Judit, Billan, Salem, Nole, Franco, Fujimoto, Yasushi, Hanai, Nobuhiro, Hara, Hiroki, Shimizu, Yasushi, Sugasawa, Masashi, Takahashi, Shunji, Tanaka, Kaoru, Ueda, Tsutomu, Wan Ishak, Wan Zamaniah, Gonzalez Mendoza, Rene, Buter, Jan, Hoeben, Ann, Bratland, Aase, Querol, John, Regala, Eugenio Emmanuel, Villegas, Ellie May, Karpenko, Andrey, Zarubenkov, Oleg, Cohen, Graham, du Toit, Johanna, Jordaan, Christa, Landers, Gregory, Ruff, Paul, Tabane, Neonyana, Brana, Irene, Iglesias Docampo, Lara, Abel, Edvard, Muratidu, Valentina, Nielsen, Niels, Cristina, Valerie, Rothschild, Sacha, Yang, Muh-Hwa, Yeh, Su-Peng, Ngamphaiboon, Nuttapong, Cicin, Irfan, Ekenel, Meltem, Harrington, Kevin, Ali, Haythem, Anderson, Daniel, Bruce, Justine, Halmos, Balazs, Hegde, Upendra, Khan, Saad, Martincic, Danko, McCune, Steven, Misiukiewicz, Krzysztof, Neupane, Prakash, Nunnink, Johannes, O'Malley, Meaghan, Powell, Steven, Redman, Rebecca, Rella, Vincent, Rocha Lima, Chaio, Wong, Stuart
Published in The Lancet (British edition)